PhaseRx Inc (PZRXQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
PhaseRx Cash from Financing (TTM): -0.532M for Sept. 30, 2017
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2017 | -0.532M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 22.61M |
| December 31, 2016 | 22.17M |
| Date | Value |
|---|---|
| September 30, 2016 | 27.06M |
| June 30, 2016 | 28.13M |
| March 31, 2016 | 6.897M |
| December 31, 2015 | 7.353M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| FluoroPharma Medical Inc | 0.6153M |
| RenovaCare Inc | -- |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | 0.7741M |
| Regenerx Biopharmaceuticals Inc | -- |